Dean S. Elterman, MD, MSC, FRCSC

Dean S. Elterman, MD, MSC, FRCSC

University of Toronto

Toronto, Ontario, Canada

Dr. Dean S. Elterman completed his medical degree followed by residency in urologic surgery at the University of Toronto. He became a fellow of the Royal College of Physicians and Surgeons of Canada in 2011. Dr. Elterman completed a two-year fellowship in Voiding Dysfunction, Neuro-Urology, Female Urology and Pelvic Reconstruction at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital/Weill Cornell Medical College in New York City.

Dr. Elterman has worked in the areas of men’s health and survivorship at the Iris Cantor Men’s Health Center at New York Presbyterian Hospital/Weill Cornell Medical College and at the University of Toronto. He is the Medical Director of the Prostate Cancer Rehabilitation Clinic at Princess Margaret Hospital Cancer Centre.

He completed his Masters degree in Clinical Epidemiology and Health Services Research at Weill Cornell Graduate School of Medical Sciences.

Dr. Elterman is a member of several professional societies including the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, the Society of Genitourinary Reconstructive Surgeons, the International Neuromodulation Society, and the International Society of Men’s Health.

Talks by Dean S. Elterman, MD, MSC, FRCSC

Optilume® BPH Catheter System: Surgical Procedure and BPH Patient Management

E. David Crawford, MD, Dean S. Elterman, MD, MSC, FRCSC, and Garrett D. Pohlman, MD, explore the practical functionality of the Optilume® BPH Catheter System, a novel minimally-invasive surgical therapy (MIST). This is the third in a series supported by Laborie.

Dr. Elterman begins with a step-by-step demonstration of the Optilume® BPH Catheter System’s surgical procedure. For each step, he provides his perspective on best practices during the procedure.

Dr. Pohlman then discusses the management of BPH patients and the patient’s perspective on what successful treatment looks like. He addresses pretreatment guidance and counseling for BPH patients who are eligible for the Optilume® BPH Catheter System, i.e., patients looking for a minimally-invasive BPH treatment without the need for medication.

Dr. Crawford concludes by asking Dr. Elterman and Dr. Pohlman for their perspectives on patient and physician reception of the Optilume® BPH Catheter System in their practices. Dr. Pohlman discusses his experiences with reimbursement, significant flow improvement, and options for balloon sizing. Dr. Elterman discusses the durability of patient QoL improvement, limited catheter time, and sexual function preservation.

To see the first part of this series, click here. To see the second part of this series, click here.

Read More

Optilume® BPH Catheter System: Surgical Procedure and BPH Patient Management – Q&A Session

E. David Crawford, MD, Dean S. Elterman, MD, MSC, FRCSC, and Garrett D. Pohlman, MD, explore the practical functionality of the Optilume® BPH Catheter System, a novel minimally-invasive surgical therapy (MIST). This is the third in a series supported by Laborie.

Dr. Elterman begins with a step-by-step demonstration of the Optilume® BPH Catheter System’s surgical procedure. For each step, he provides his perspective on best practices during the procedure.

Dr. Pohlman then discusses the management of BPH patients and the patient’s perspective on what successful treatment looks like. He addresses pretreatment guidance and counseling for BPH patients who are eligible for the Optilume® BPH Catheter System, i.e., patients looking for a minimally-invasive BPH treatment without the need for medication.

Dr. Crawford concludes by asking Dr. Elterman and Dr. Pohlman for their perspectives on patient and physician reception of the Optilume® BPH Catheter System in their practices. Dr. Pohlman discusses his experiences with reimbursement, significant flow improvement, and options for balloon sizing. Dr. Elterman discusses the durability of patient QoL improvement, limited catheter time, and sexual function preservation.

To see the first part of this series, click here. To see the second part of this series, click here.

Read More

Optilume® BPH Catheter System: Optilume® BPH Product and Clinical Data Overview

E. David Crawford, MD, sits down with Dean S. Elterman, MD, MSC, FRCSC, and Stephen Kaplan, MD, to discuss the evolution of BPH treatment and the Optilume® BPH Catheter System, a novel minimally-invasive surgical therapy (MIST). This is the first in a series supported by Laborie.

Dr. Elterman begins with an overview of the Optilume® BPH Drug Coated Balloon Catheter. He presents the components of the system and their utility. He presents a demonstration of the system in action.

Dr. Kaplan presents data from the clinical investigations of the effectiveness of the Optilume® BPH Catheter System. He provides an overview of the results from the EVEREST study and the landmark PINNACLE trial, which was published in the September 2023 issue of the Journal of Urology. He notes that the major benefits of the treatment include significant flow rate improvement despite the lack of tissue removal and low surgical retreatment rates.

Read More

Join the GRU Community

- Why Join? -